Pharmaceutical

Merck agrees to acquire Verona Pharma for $10bn

Merck has entered a definitive agreement to acquire biopharmaceutical company Verona Pharma in a deal valued at $10bn.

Jul 11, 2025 - 06:00
Merck agrees to acquire Verona Pharma for $10bn
Merck has entered a definitive agreement to acquire biopharmaceutical company Verona Pharma in a deal valued at $10bn.
Read the original article

Tags:

Previous Article

Lupin and Zentiva in licence and supply deal for Certolizumab Pegol

Next Article

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Gene...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

MEDI-0618 by AstraZeneca for Migraine: Likelihood of Ap...

Jun 18, 2024

DMD market expected to grow to $5.2bn in the 7MM by 2033

DMD market expected to grow to $5.2bn in the 7MM by 2033

Feb 15, 2025

Orbit and Evergreen partner to advance radiopharmaceuticals development

Orbit and Evergreen partner to advance radiopharmaceuti...

Apr 4, 2023